Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects
Author(s) -
Anna FC Schut,
Gysèle S. Bleumink,
Bruno H. Stricker,
Albert Hofman,
Jacqueline C.M. Witteman,
H. A. P. Pols,
J. W. Deckers,
Jaap Deinum,
Cornelia M. van Duijn
Publication year - 2004
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1016/j.ehj.2004.08.026
Subject(s) - medicine , heart failure , angiotensin converting enzyme , rotterdam study , cardiology , genotype , left ventricular hypertrophy , population , endocrinology , incidence (geometry) , prospective cohort study , blood pressure , genetics , physics , environmental health , biology , optics , gene
Cardiac angiotensin-I converting enzyme (ACE) activity is influenced by the ACE I/D polymorphism. Evidence suggests that the DD-genotype may be a risk factor for cardiac hypertrophy and heart failure, especially in hypertensive subjects. We assessed the relation between the ACE I/D polymorphism and the risk of incident heart failure in normotensive and hypertensive subjects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom